AbbVie Acquires Arizona Manufacturing Facility, Further Strengthening Manufacturing Capabilities in the U.S.
On Jan. 12, 2026, AbbVie and West Pharmaceutical Services announced a definitive agreement for AbbVie to acquire a…
-
-
Oxford University enters into licensing arrangement with Serum Institute of India to develop Rift Valley fever vaccine candidate
On Jan. 12, 2026, With support from the epidemic preparedness organisation Coalition for Epidemic Preparedness Innovations (CEPI), Serum…
-
Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida
On Jan. 9, 2026, Novartis announced plans to build its fourth US radioligand therapy (RLT) manufacturing facility in…
-
Mount Sinai Researchers Help Create Largest Immune Cell Atlas of Bone Marrow in Multiple Myeloma Patients
On Jan. 9, 2026, scientists at the Icahn School of Medicine at Mount Sinai, in partnership with the Multiple Myeloma Research…
-
Stem cell engineering breakthrough paves way for next-generation living drugs
On Jan. 8, 2026, for the first time, researchers at the University of British Columbia have demonstrated how…
-
Chinese drug makers strike a record US$136 billion in out-licensing deals in 2025
On Jan. 8, 2026, Chinese drug makers’ licensing deals more than doubled in 2025 from a year earlier…
-
How some people get drunk from their own gut bacteria
On Jan. 8, 2026, researchers reported results from a study on the largest cohort of autobrewery syndrome (ABS)…
-
Lilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseases for $1.2 billion
On Jan. 7, 2025, Eli Lilly and Ventyx Biosciences, a San Diego-based clinical-stage biopharmaceutical company focused on developing…
-
Widely used pesticide linked to more than doubled Parkinson’s risk
On Jan. 7, 2026, a study from the University of California, Los Angeles (UCLA) Health found that long-term…
-
CDC Reports 2025 Measles Outbreak the highest in More Than Thirty Years
On Jan. 6, 2026, the U.S. Centers for Disease Control and Prevention (CDC) reported that for the full…
-
Amgen Acquires Dark Blue Therapeutics for $840 Million
On Jan. 6, 2026, Amgen announced its acquisition of Dark Blue Therapeutics, a privately held biotechnology company based…
-
Four Flu-Related Deaths Among Children in Boston
On Jan. 6, 2026, the Boston Public Health Commission (BPHC) is informing residents that flu has been associated…
-
Some antibodies outmaneuver germs from sticking to cells
On Jan. 6, 2026, a study led by University of Washington School of Medicine researchers uncovered several new…
-
Biotechnology | CDC | Disease | FDA | Vaccine
West Coast Health Alliance Recommends American Academy of Pediatrics Vaccine Schedule
On Jan. 5, 2026, the Acting Director of the Centers for Disease Control and Prevention signed a decision…
-
Novo Nordisk’s Wegovy® pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America
On Jan. 5, 2026, Novo Nordisk announced that the Wegovy® pill is now available, providing those seeking help…
-
Researchers Identify Proteins that Spread Parkinson’s Pathology in the Brain
On Jan. 5, 2026, Yale School of Medicine (YSM) research report that two proteins found on the surface…
-
Flu season surged in the U.S. over the holiday and already rivals last winter’s harsh epidemic
On Jan. 5, 2026, U.S. flu infections surged over the holidays, and health officials are calling it a…
-
FDA approves Novo Nordisk’s Wegovy® pill, the first and only oral GLP-1 for weight loss in adults
On Dec. 22, 2025, Novo Nordisk announced announced that the US Food and Drug Administration (FDA) has approved…
-
Scientists Map the Human Genome in 4D
On Dec. 22, 2025, scientists at Northwestern University announced a landmark effort to understand how the physical structure…
-
Biotechnology | CMO | CRO | Genomics | Therapeutics | Vaccine
Samsung Biologics Expands U.S. Manufacturing Capabilities with Acquisition of Human Genome Sciences from GSK
On Dec. 21, 2025, Samsung Biologics announced that its wholly owned U.S. subsidiary, Samsung Biologics America, has entered…
-
FDA Announces Approval of Cytokinetics’ MYQORZO™ (aficamten) for Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy
On Dec. 19, 2025, Cytokinetics announced that the U.S. Food and Drug Administration (FDA) has approved MYQORZO™ (aficamten),…
-
Biotechnology | COVID-19 | Diagnostics | Genomics | Infectious Disease | Influenza | Measles | Plague | Polio | Vaccine
A century of emergence: trends and patterns in human viral pathogens, 1900–2024, a systematic review
On Dec. 20, 2025, a new study published in the journal BMC Infectious Diseases reported that viral emergence…
-
Novartis and U.S. government reach agreement on lowering drug prices
On Dec. 19, 2025, Novartis, a leading global innovative medicines company, announced it has reached an agreement with…
-
BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases
On Dec. 19, 2025, BioMarin Pharmaceutical and Amicus Therapeutics announced that BioMarin has entered into a definitive agreement…
-
CRISPR primes goldenberry for fruit bowl fame
On Dec. 19, 2025, Cold Spring Harbor Laboratory (CSHL) plant biologists may have found a “shortcut” to this…
-
Biotechnology | Diagnostics | HIV | Therapeutics | Vaccine | WHO | Women's Health
WHO validates Brazil for eliminating mother-to-child transmission of HIV
On Dec. 18, 2025, the World Health Organization (WHO) announced it has validated Brazil for the elimination of…
-
Space Station Research Supports New FDA-Approved Cancer Therapy
On Dec. 18, 2025, the National Aeronautics and Space Administration (NASA) announced it has opened the International Space…
-
Novo Nordisk files for FDA approval of CagriSema, the first once-weekly combination of GLP‑1 and amylin analogues for weight management
On Dec. 18, 2025, Novo Nordisk announced the submission of a New Drug Application (NDA) to the U.S….
-
Israeli, US scientists uncover viral switch that could help defeat antibiotic resistance
On Dec. 18, 2025, scientists at the Hebrew University of Jerusalem revealed that bacteriophages use a small RNA…
-
WHO Releases Statement on the antigen composition of COVID-19 vaccines
On Dec. 18, 2025, the World Health Organization (WHO) Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC) announced…
